Cargando…

Inhibitor of apoptosis proteins in breast cancer

Detalles Bibliográficos
Autores principales:	Foster, FM, Streuli, CH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300256/ http://dx.doi.org/10.1186/bcr1564

Ejemplares similares

Inhibitor of apoptosis proteins as a therapeutic target in breast cancer
por: Foster, FM, et al.
Publicado: (2008)

Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy
por: Owens, Thomas W, et al.
Publicado: (2013)

Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer
por: Foster, Fiona M, et al.
Publicado: (2009)

Molecular control of apoptosis in the breast
por: Streuli, C, et al.
Publicado: (2000)

Mitochondrial translocator protein modulates metabolism and pharmacologically induced apoptosis in breast cancer cells
por: Gastaldello, A, et al.
Publicado: (2010)

Effects of recombinant surfactant protein C and elastase inhibitor on neutrophil apoptosis
por: Pravinkumar, E, et al.
Publicado: (2004)

Investigation of the roles of novel apoptosis-controlling genes in breast cancer
por: Williams, GT, et al.
Publicado: (2008)

Cellular localization of the proto-oncogenic p53 inhibitor AGR2 protein in breast cancer
por: Fourtouna, A, et al.
Publicado: (2008)

PB.48: Old habits die hard: breast imaging of symptomatic 35 to 39 year olds
por: Singh, FM, et al.
Publicado: (2013)

Living with genetic risk of breast cancer: what have we learned?
por: Foster, C
Publicado: (2008)

Role for X-linked Inhibitor of Apoptosis Protein Upstream of Mitochondrial Permeabilization
por: Owens, Thomas W., et al.
Publicado: (2010)

Characterising an aromatase inhibitor resistant breast cancer cell line
por: Harris, E, et al.
Publicado: (2012)

Inhibition of apoptosis by Notch signalling in breast epithelial cells
por: Meurette, O, et al.
Publicado: (2008)

Role of CASP8 D302H and other apoptosis gene variants in breast cancer
por: Mistry, SH, et al.
Publicado: (2006)

Role of protein kinase B in breast cancer
por: Sale, EM, et al.
Publicado: (2006)

The effect of cyclooxygenase-2 selective inhibitors on the proliferation and apoptosis of human articular chondrocytes
por: Song, YW, et al.
Publicado: (2003)

Analysis of inhibitor of apoptosis protein family expression during mammary gland development
por: Owens, Thomas W, et al.
Publicado: (2010)

Genetic engineering of pharmacologically regulated T cells, specific for breast cancer target antigens
por: Wilkie, S, et al.
Publicado: (2010)

Stick or switch? Audit of the use of switch therapy from tamoxifen to an aromatase inhibitor in breast cancer
por: Weeraman, S, et al.
Publicado: (2010)

Functions of novel Junctional Adhesion Molecule-A (JAM-A) inhibitor in breast cancer cells
por: Lim, XY, et al.
Publicado: (2015)

Nebulized Cl-esterase inhibitor treatment does not attenuate pulmonary complement activation in a rat model of severe Streptococcus pneumoniae pneumonia
por: De Beer, FM, et al.
Publicado: (2014)

ACVR1 mutation and Fibrodysplasia Ossificans Progressiva in Chinese children
por: Ho, Assunta CH, et al.
Publicado: (2011)

A novel small-molecule SIRT1 inhibitor induces apoptosis in leukemic cell lines
por: Kozako, Tomohiro, et al.
Publicado: (2014)

Exploring the breast cancer experiences, needs and preferences of women aged 70 years and over: a study in progress
por: Moffat, J, et al.
Publicado: (2008)

A novel and selective PDK1 inhibitor reduces breast cancer cell invasion and tumour growth
por: Raimondi, C, et al.
Publicado: (2010)

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014)

ZD6474 in combination with paclitaxel and UVB irradiation enhances the antiproliferative effect and apoptosis on breast carcinoma
por: Sarkar, S, et al.
Publicado: (2009)

Quantitative proteomics reveals proteins associated with radiotherapy resistance in breast cancer cells
por: Smith, L, et al.
Publicado: (2008)

PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer
por: Hay, T, et al.
Publicado: (2008)

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples
por: Gámez-Pozo, A, et al.
Publicado: (2011)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, Lars, et al.
Publicado: (2008)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, L, et al.
Publicado: (2009)

Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
por: Ottewell, PD, et al.
Publicado: (2008)

AGR2, a novel metastasis inducing protein with an effect on breast cancer patient survival
por: Barraclough, DL, et al.
Publicado: (2006)

Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer
por: Løkkegaard, S, et al.
Publicado: (2011)

Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors
por: Gong, Jian, et al.
Publicado: (2014)

Viral FLICE inhibitory protein of Rhesus monkey rhadinovirus inhibits apoptosis by enhancing autophagosome formation
por: Ritthipichai, Krit, et al.
Publicado: (2012)

A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
por: Twiddy, D, et al.
Publicado: (2010)

Developmental protein HOXC11 cooperates with SRC-1 in breast cancer: an adaptive response to endocrine therapy
por: McIlroy, M, et al.
Publicado: (2010)

Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy
por: Foulstone, EJ, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ajg4klutl51drpqol4jhr3rdak